For this month #EUSTAR#YIGs#JC YIGs have chosen this article by Mirizio et al. about Genetic Signatures in Pediatric Localized Scleroderma Skin that provides a better understanding of the underlying immune and pro-fibrotic pathways pubmed.ncbi.nlm.nih.gov/34164359/

For this month #EUSTAR #YIGs #JC Dr. Lescoat selected this article by Manfredi et al. showing neutrophil/platelet interactions and an impaired protective role of neutrophils with decreased phagocytosis of activated platelets involved in SSc vasculopathy pubmed.ncbi.nlm.nih.gov/34279048/

For the July #EUSTAR #YIGs Clinical #JC Dr. Alexandru Garaiman from University Hospital Zurich, selected the paper from Iudici et al highlighting the reasons for ineligibility in randomized controlled trials of systemic sclerosis patients. pubmed.ncbi.nlm.nih.gov/33989387/

#ACR21 Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413) EUSTAR Join Today 1:30 PM - 3:30 PM CET!!

#ACR21 6S417. Abstracts: Systemic Sclerosis & Related Disorders – Clinical (0496–0501) Join Today at 8:30 PM - 10:00 PM CET! EUSTAR Anna Hoffmann-Vold

#ACR21 (0541–0559) Systemic Sclerosis & Related Disorders – Basic Science Poster Join Today at 2:30 PM - 4:30 PM CET! EUSTAR blaz burja

#ACR21 Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390) Join Today at 2:30 PM - 4:30 PM CET EUSTAR Alex Garaiman Anna Hoffmann-Vold

#ACR21 Abstracts: Systemic Sclerosis & Related Disorders – Basic Science (1434–1437) Join Today at 4:30 PM - 5:30 PM CET! EUSTAR

#ACR21 Community Hub Scleroderma: Poster Review: Clinical Scleroderma includes #1364, #1839, & #1383 Join Today at 11:00 PM - 11:45 PM CET EUSTAR Alex Garaiman Assassi

#ACR21 Systemic Sclerosis & Related Disorders – Clinical Poster III (1836–1861) Join Today at 2:30 PM - 4:30 PM CET! EUSTAR Dr. Dinesh Khanna Julia Spierings Assassi allanore yannick

Community HUB Scleroderma: Scleroderma Highlights from #ACR21 Join Today at 6:00 PM - 6:45 PM CET! EUSTAR

✨Now here’s a Good Reason to ✅ANA✨ 🌟Stratification Tool for #Raynauds 👉 Negative #ANA at baseline STRONGLY PROTECTIVE of 📈 to #SSc 👉 Puffy 🖐 +/- SSc-Specific Abs STRONG RISK factors for progression to #SSc at 5 y ☑️ Potential 🎯 for trials #VEDOSS The Lancet Rheumatology

📢#EUSTAR and #WSF are pleased to announce the Systemic Sclerosis School on 1st-2nd April 2022 as a virtual event EUSTAR World Scleroderma Foundation EULAR #scleroderma 👉Early registration available at: ccwebcast.eu/sclerosis/ 👇 Detailed program available below:

🔷🔹🔷 #WSC22 🔹🔷🔹 _________⏰2 days to go ⏰_________ We are ready to start the 7th #SSc #worldcongress with many news and high quality educational lectures!! web.aimgroupinternational.com/2022/sclerosis…

🔷🔹🔷#WSC22 🔹🔷🔹 ⏩Stay tuned 👉 discussion session 1 #ILD will start soon. 🏃‍♀️🏃‍♂️Hurry up and login 🧑‍💻👩‍💻web.aimgroupinternational.com/2022/sclerosis… Martin Kolb Vincent Cottin Eli Volkmann @vkoether Cosimo Bruni @gbogatkevich Susanna Proudman @mkuwana

📢For this month #EUSTAR #JC #YIGs have chosen this article by Assassi et al. revealing that in SSc-ILD patients, higher baseline lymphoid lineage module scores predict better FVC% course when treated with MMF #PrecisionMedicine #scleroderma 👉pubmed.ncbi.nlm.nih.gov/35190386/

📢For the March #EUSTAR #YIGs basic science #JC, YIGs have chosen this article by Karatas et al, investigating tofacitinib and metformin in a mouse model of SSc 👉pubmed.ncbi.nlm.nih.gov/35169250/

I am happy to share our last paper, result of a beautiful collaboration! Thanks GILS and Fira for the support! Marco matucci cerini MariaelenaOcchipinti

Are you a #Cardiology or #rheumatology physician taking care of #scleroderma patients? We want to hear your opinion on the definition and consensus from WSF World Scleroderma Foundation & HFA of European Society of Cardiology! #answer this #survey and #spread it to your network! forms.gle/pkkARxwnEj3Z1e…

🔝 of SSc science session: amazing talk about the consensus and definition of primary SSc heart ❤️ involvement by Cosimo Bruni, SSc-pHI project 2018-2022 Carmen Pilar Simeón Clara Soto